Welcome to the Calvert Research Institute website, a connection point for investors and emerging biodiscovery companies.

NAMING THE GAP
Biotechnical, pharmaceutical, nutraceutical and medical device development are complex businesses. Start-ups are hard-pressed to obtain investors, acquire and direct staff, locate development and testing resources, and evaluate marketing strategies all while focusing on development of their core science. Investors want to know that an emerging company can manage the risks inherent in drug development, and often want to see a particular level of maturity before contributing to the new venture.

OUR GENESIS
Calvert Research Institute was precisely formed to bridge this gap in the early-stage drug and device development cycle. We have implemented an innovative model of strategic partnering and can utilize the virtual nature of a consortium of specialized companies and services so that investment communities and start-ups both achieve their goals.